EyeGate Pharmaceuticals, Inc.
(NASDAQ : EYEG)

( )
EYEG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
-0.05%84.0320.1%$620.21m
AMRNAmarin Corp. Plc
0.17%23.031.7%$275.45m
VRXValeant Pharmaceuticals International, Inc.
0.02%31.8914.1%$187.65m
ARQLArQule, Inc.
-1.04%19.990.6%$140.34m
SAGESAGE Therapeutics, Inc.
6.08%77.008.6%$137.07m
BHCBausch Health Cos., Inc.
0.02%31.890.0%$132.19m
ICPTIntercept Pharmaceuticals, Inc.
0.54%116.5516.9%$94.62m
JAZZJazz Pharmaceuticals Plc
1.20%149.902.3%$91.82m
GWPHGW Pharmaceuticals Plc
2.74%105.706.2%$86.29m
PRGOPerrigo Co. Plc
1.36%54.546.8%$65.30m
AXSMAxsome Therapeutics, Inc.
0.37%48.752.0%$60.48m
HZNPHorizon Therapeutics Plc
1.83%32.846.6%$44.72m
ICLRICON plc
-0.10%161.574.2%$42.46m
UTHRUnited Therapeutics Corp.
1.37%93.7614.3%$36.17m
ENDPEndo International Plc
7.06%4.708.8%$33.53m

Company Profile

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.